Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 179

1.

Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families.

Biesecker BB, Ishibe N, Hadley DW, Giambarresi TR, Kase RG, Lerman C, Struewing JP.

Am J Med Genet. 2000 Aug 14;93(4):257-63.

PMID:
10946349
[PubMed - indexed for MEDLINE]
2.

BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.

Lerman C, Narod S, Schulman K, Hughes C, Gomez-Caminero A, Bonney G, Gold K, Trock B, Main D, Lynch J, Fulmore C, Snyder C, Lemon SJ, Conway T, Tonin P, Lenoir G, Lynch H.

JAMA. 1996 Jun 26;275(24):1885-92.

PMID:
8648868
[PubMed - indexed for MEDLINE]
3.

Factors associated with decisions about clinical BRCA1/2 testing.

Armstrong K, Calzone K, Stopfer J, Fitzgerald G, Coyne J, Weber B.

Cancer Epidemiol Biomarkers Prev. 2000 Nov;9(11):1251-4.

PMID:
11097234
[PubMed - indexed for MEDLINE]
Free Article
4.

What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing.

Lerman C, Hughes C, Lemon SJ, Main D, Snyder C, Durham C, Narod S, Lynch HT.

J Clin Oncol. 1998 May;16(5):1650-4.

PMID:
9586874
[PubMed - indexed for MEDLINE]
5.

BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention.

McInerney-Leo A, Biesecker BB, Hadley DW, Kase RG, Giambarresi TR, Johnson E, Lerman C, Struewing JP.

Am J Med Genet A. 2004 Oct 15;130A(3):221-7.

PMID:
15378542
[PubMed - indexed for MEDLINE]
6.

Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing.

Lodder L, Frets PG, Trijsburg RW, Tibben A, Meijers-Heijboer EJ, Duivenvoorden HJ, Wagner A, van Der Meer CA, Devilee P, Cornelisse CJ, Niermeijer MF.

Eur J Hum Genet. 2001 Jul;9(7):492-500.

PMID:
11464240
[PubMed - indexed for MEDLINE]
Free Article
7.

Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.

Di Prospero LS, Seminsky M, Honeyford J, Doan B, Franssen E, Meschino W, Chart P, Warner E.

CMAJ. 2001 Apr 3;164(7):1005-9.

PMID:
11314429
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

BRCA1/2 testing in hereditary breast and ovarian cancer families II: impact on relationships.

McInerney-Leo A, Biesecker BB, Hadley DW, Kase RG, Giambarresi TR, Johnson E, Lerman C, Struewing JP.

Am J Med Genet A. 2005 Mar 1;133A(2):165-9.

PMID:
15633195
[PubMed - indexed for MEDLINE]
9.

Genetic testing for breast-ovarian cancer susceptibility: a regional trial.

Loader S, Levenkron JC, Rowley PT.

Genet Test. 1998;2(4):305-13.

PMID:
10464609
[PubMed - indexed for MEDLINE]
10.

Genetic counseling for BRCA1/BRCA2 testing.

Schneider KA.

Genet Test. 1997;1(2):91-8.

PMID:
10464632
[PubMed - indexed for MEDLINE]
11.

A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.

Machácková E, Foretová L, Navrátilová M, Valík D, Claes K, Messiaen L.

Cas Lek Cesk. 2000 Oct 11;139(20):635-7.

PMID:
11192759
[PubMed - indexed for MEDLINE]
12.

Attitudes and distress levels in women at risk to carry a BRCA1/BRCA2 gene mutation who decline genetic testing.

Lodder L, Frets PG, Trijsburg RW, Klijn JG, Seynaeve C, Tilanus MM, Bartels CC, Meijers-Heijboer EJ, Verhoog LC, Niermeijer MF.

Am J Med Genet A. 2003 Jun 15;119A(3):266-72.

PMID:
12784290
[PubMed - indexed for MEDLINE]
13.

Evaluation of the needs of male carriers of mutations in BRCA1 or BRCA2 who have undergone genetic counseling.

Liede A, Metcalfe K, Hanna D, Hoodfar E, Snyder C, Durham C, Lynch HT, Narod SA.

Am J Hum Genet. 2000 Dec;67(6):1494-504. Epub 2000 Nov 3.

PMID:
11063672
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds.

Casey MJ, Bewtra C, Hoehne LL, Tatpati AD, Lynch HT, Watson P.

Gynecol Oncol. 2000 Sep;78(3 Pt 1):278-87. Review.

PMID:
10985881
[PubMed - indexed for MEDLINE]
15.

Impact of educational print materials on knowledge, attitudes, and interest in BRCA1/BRCA2: testing among Ashkenazi Jewish women.

Schwartz MD, Benkendorf J, Lerman C, Isaacs C, Ryan-Robertson A, Johnson L.

Cancer. 2001 Aug 15;92(4):932-40.

PMID:
11550168
[PubMed - indexed for MEDLINE]
16.

First BRCA1 and BRCA2 gene testing implemented in the health care system of Stockholm.

Arver B, Borg A, Lindblom A.

Genet Test. 2001 Spring;5(1):1-8.

PMID:
11336395
[PubMed - indexed for MEDLINE]
17.

Psychosocial issues associated with genetic testing for breast and ovarian cancer risk: an integrative review.

Pasacreta JV.

Cancer Invest. 2003;21(4):588-623. Review.

PMID:
14533449
[PubMed - indexed for MEDLINE]
18.

An update on DNA-based BRCA1/BRCA2 genetic counseling in hereditary breast cancer.

Lynch HT, Watson P, Tinley S, Snyder C, Durham C, Lynch J, Kirnarsky Y, Serova O, Lenoir G, Lerman C, Narod SA.

Cancer Genet Cytogenet. 1999 Mar;109(2):91-8.

PMID:
10087939
[PubMed - indexed for MEDLINE]
19.

Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry.

Nanda R, Schumm LP, Cummings S, Fackenthal JD, Sveen L, Ademuyiwa F, Cobleigh M, Esserman L, Lindor NM, Neuhausen SL, Olopade OI.

JAMA. 2005 Oct 19;294(15):1925-33.

PMID:
16234499
[PubMed - indexed for MEDLINE]
20.

Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.

Casey MJ, Synder C, Bewtra C, Narod SA, Watson P, Lynch HT.

Gynecol Oncol. 2005 May;97(2):457-67.

PMID:
15863145
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk